missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human TLR3 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 1487-TR-050
260.04 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
The Recombinant Human TLR3 Protein is derived from NS0. The Recombinant Human TLR3 Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 79.2 kDa | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| Measured by its ability to inhibit poly I:C induced IL-8 secretion by HEK293 human embryonic kidney cells transfected with TLR3. The ED50 for this effect is 5-10 μg/mL in the presence of 0.2 μg/mL of poly I:C. |
| 7098 | |
| TLR3 | |
| Mouse myeloma cell line,NS0-derived human TLR3 protein Lys27-Ser711,with a C-terminal 10-His tag | |
| <0.10 EU per 1 μg of the protein by the LAL method. | |
| Recombinant | |
| >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining. |